Myriad Genetics, Inc. (MYGN) Expands Its Patient Financial Assistance Program
7/16/2013 9:51:59 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SALT LAKE CITY, July 15, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced a program to provide financial assistance to underinsured patients. Beginning July 22, Myriad will offer financial assistance to reduce qualified underinsured patients' out-of-pocket cost to no more than $375. To be eligible, patients must have private insurance, meet their insurance's coverage criteria for testing, and meet low income requirements (household incomes up to 200 percent of the Federal poverty level). This expansion of Myriad's financial assistance program to underinsured patients complements the free testing Myriad currently offers for low income uninsured patients.
Help employers find you! Check out all the jobs and post your resume.
comments powered by